Zhuhai Beihai Biotechnology Co., Ltd.

Venture capital and private equity firms pumped moderate amounts of cash into Chinese biotechnology start-ups in December 2023, with many of the financing deals focused on oncology. Innovo Therapeutic

Cell therapy developers took the lion’s share of private equity and venture capital funds raised in China in October, with three firms bagging north of CNY300m ($41m) in total. On 31 October, Beijing